Stockreport

Lava Therapeutics jumps 9% after receiving FDA Orphan Drug tag for LAVA-051 in blood cancer [Seeking Alpha]

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF Lava Therapeutics jumps 9% after receiving FDA Orphan Drug tag for LAVA-051 in blood cancer [Read more]